Eam Global Investors LLC Catalyst Pharmaceuticals, Inc. Transaction History

Eam Global Investors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $584,913 - $931,086	-47,748 Reduced 29.98%	111,542 $2.07 Million
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $612,003 - $1.35 Million	-86,686 Reduced 35.24%	159,290 $2.04 Million
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $291,495 - $400,981	-46,789 Reduced 15.98%	245,976 $1.72 Million
Q1 2022 May 13, 2022	SELL	$5.31 - $8.31 $292,761 - $458,163	-55,134 Reduced 15.85%	292,765 $2.43 Million
Q4 2021 Feb 11, 2022	BUY	$5.21 - $7.45 $1.81 Million - $2.59 Million	347,899 New	347,899 $2.36 Million
Q2 2019 Aug 14, 2019	SELL	$2.7 - $6.11 $745,815 - $1.69 Million	-276,228 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$2.11 - $5.33 $582,841 - $1.47 Million	276,228 New	276,228 $1.41 Million
Q1 2018 Jun 04, 2018	SELL	$2.39 - $4.01 $601,436 - $1.01 Million	-251,647 Closed	0 $0
Q4 2017 Jun 04, 2018	BUY	$2.51 - $4.4 $631,633 - $1.11 Million	251,647	251,647 $984,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.